Showing 2521-2530 of 2839 results for "".
- Lutronic Introduces Accufit for Muscle Stimulationhttps://modernaesthetics.com/news/lutronic-introduces-accufit-for-muscle-stimulation/2473014/Lutronic is launching Accufit, a new device for targeted muscle activation. Eight IntelliSTIM electrodes distribute energy and generate strong muscular contractions on any area needed to be treated without pain or skin sensitivity. Accufit's IntelliPhase waveforms p
- Ransomware Alert: Government Advisory Suggests Threat to Healthcare Systemhttps://modernaesthetics.com/news/ransomware-alert-government-advisory-suggests-threat-to-healthcare-system/2473012/A new advisory coauthored by the Cybersecurity and Infrastructure Security Agency (CISA), the Federal Bureau of Investigation (FBI), and the Department of Health and Human Services (HHS) warns of the potential for ransomware attacks against hospitals and medical systems. “CI
- TrueHero Face Shields Available for Medical Practiceshttps://modernaesthetics.com/news/truehero-face-shields-available-for-medical-practices/2473005/Responding to the need for PPE across the US, Jamestown Plastics, has pivoted production to manufacture face shields to protect from COVID-19. The TrueHero Extreme Coverage Shield is suitable for medical use, including in dermatology and aesthetic practices.
- BTL Launches Emsculpt NEOhttps://modernaesthetics.com/news/btl-launches-emsculpt-neo/2473004/The first procedure to combine radio frequency heating and high-intensity focused electromagnetic waves into a single therapy, Emsculpt NEO from BTL, has launched. It is FDA-cleared to eliminate fat cells non-invasively. Emsc
- Allergan Buys Luminera Dermal-Filler Businesshttps://modernaesthetics.com/news/allergan-buys-luminera-dermal-filler-business/2473000/Allergan Aesthetics, an AbbVie company, has acquired Luminera's full dermal filler portfolio and R&D pipeline. Luminera is a privately held aesthetics company based in Israel with a portfolio and pipeline of dermal filler products. "
- Suneva, Neauvia Partner to Market and Distribute Plasma IQ in North Americahttps://modernaesthetics.com/news/suneva-neauvia-partner-to-market-and-distribute-plasma-iq-in-north-america-1/2472993/Suneva Medical, Inc., will market and distribute Neauvia Plasma IQ throughout North America as part of a new partnership. The first Class 2 FDA-cleared plasma energy device, Plasma IQ delivers focused, controlled plasma energy to create microinjuries on the skin, renewing
- Allergan Aesthetics and Skinbetter Science Launch The DREAM Initiative to Advance Health Equity and Diversity in Aestheticshttps://modernaesthetics.com/news/allergan-aesthetics-and-skinbetter-science-launch-the-dream-initiative-to-advance-health-equity-and-diversity-in-aesthetics/2472990/Allergan Aesthetics, an AbbVie company, and Skinbetter Science have jointly launched a new long-term, educational initiative—DREAM: Driving Racial Equity in Aesthetic Medicine. The DREAM Initiative™ is committed to furthering the principles of racial and ethnic diversity, inclus
- NYC Dermatologist Dr. Doris Day Joins Nufabrx’s Ad Boardhttps://modernaesthetics.com/news/nyc-dermatologist-dr-doris-day-joins-nufabrxs-ad-board/2472988/New York City dermatologist Doris Day, MD is the newest member of Nufabrx’s advisory board. Nufabrx is an advanced textiles company that has developed a proprietary biomaterial platform that embeds active ingredient
- Amore Pacific Gets Woke with Enough Project Lifestyle Brandhttps://modernaesthetics.com/news/amore-pacific-gets-woke-with-enough-project-lifestyle-brand/2472983/South Korea’s Amorepacific is launching its newest vegan-friendly lifestyle brand: Enough Project. This new brand is vegan-friendly, involves no animal testing, and contains no animal ingredients. In a
- New from Lumenis: Meet NuEra Tighthttps://modernaesthetics.com/news/new-from-lumenis-meet-nuera-tight/2472982/Lumenis is rolling out the NuEra Tight with FocalRF technology for body contouring. NuEra Tight will be available worldwide starting with the United States in August 2020 and Europe, the Middle East and Asia later this year. "Radio Frequency treatments are among the most